Search Results - "Quaglino, Pietro"
-
1
In Vivo Observation of Cutaneous Larva Migrans by Fluorescence-Advanced Videodermatoscopy
Published in Emerging infectious diseases (01-01-2021)“…Fluorescence-advanced videodermatoscopy is not a widespread diagnostic technique. Its application in dermatology can facilitate the diagnosis of diseases such…”
Get full text
Journal Article -
2
Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series
Published in Acta dermato-venereologica (28-09-2022)“…Abstract is missing (Short communication)…”
Get full text
Journal Article -
3
In Vivo Observation of Trombiculosis with Fluorescence-Advanced Videodermatoscopy
Published in Emerging infectious diseases (01-08-2020)“…Trombiculosis is a skin infestation by larvae of mites of the Trombiculidae family. We used fluorescence-advanced videodermatoscopy to diagnose trombiculosis…”
Get full text
Journal Article -
4
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients
Published in Scientific reports (25-09-2020)“…Detection of BRAF V600E within cell free tumor DNA (ctDNA) is emerging as a promising means to improve patients’ stratification or enable BRAF inhibitor…”
Get full text
Journal Article -
5
The Limitation of Accessing Hospital Services Due to COVID-19 Pandemic: A Pilot Study of the Telephone Triage to Re-Organize the Access to a Center for Sexual Health in Northwest Italy
Published in Sexually transmitted diseases (01-09-2023)“…The COVID-19 pandemic-related health crisis has imposed measures aimed at reducing the overcrowding of health facilities, by developing telemedicine and by…”
Get full text
Journal Article -
6
Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study
Published in Acta dermato-venereologica (19-04-2023)“…Abstract is missing (Short communication)…”
Get full text
Journal Article -
7
Cutaneous T cell lymphoma
Published in Nature reviews. Disease primers (26-08-2021)“…Primary cutaneous T cell lymphomas (CTCLs) are a heterogeneous group of lymphomas that present in the skin with no evidence of extracutaneous disease at the…”
Get full text
Journal Article -
8
Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers
Published in Frontiers in oncology (18-05-2022)Get full text
Journal Article -
9
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement
Published in Scientific reports (18-05-2021)“…Folliculotropic Mycosis Fungoides (FMF) is a rare variant of Mycosis Fungoides involving the scalp leading to alopecia. The clinical and trichoscopic features…”
Get full text
Journal Article -
10
Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy
Published in Acta dermato-venereologica (29-11-2022)“…Psoriatic patients with latent tuberculosis infection and properly treated active tuberculosis need careful management when prescribing modern biological…”
Get full text
Journal Article -
11
First pilot case-control interventional study using autologous extracellular vesicles to treat chronic venous ulcers unresponsive to conventional treatments
Published in Pharmacological research (01-04-2023)“…Current therapeutic approaches for chronic venous ulcers (CVUs) still require evidence of effectiveness. Diverse sources of extracellular vesicles (EVs) have…”
Get full text
Journal Article -
12
Radiotherapy and immune checkpoints inhibitors for advanced melanoma
Published in Radiotherapy and oncology (01-07-2016)“…Abstract Introduction The therapeutic landscape of metastatic melanoma drastically changed after the introduction of targeted therapies and immunotherapy, in…”
Get full text
Journal Article -
13
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma
Published in Journal of the American Academy of Dermatology (01-12-2014)“…Background BRAF inhibitor (BRAFi) and MEK inhibitor (MEKi) frequently cause cutaneous adverse events. Objective We sought to investigate the cutaneous safety…”
Get full text
Journal Article -
14
Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
Published in Case reports in dermatology (01-09-2019)“…Upon the association of biologic treatments with reactivation of latent tuberculosis infection (LTBI), screening for Mycobacterium tuberculosisinfection and…”
Get full text
Journal Article -
15
Cutaneous T-cell Lymphoma Diagnostic and Therapeutic Trends amidst the COVID-19 Pandemic
Published in Acta dermato-venereologica (15-07-2024)“…is missing (Short communication)…”
Get full text
Journal Article -
16
Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients
Published in Pharmaceuticals (Basel, Switzerland) (17-07-2022)“…Chronic pruritus is a major symptom of atopic dermatitis (AD). Its etiopathogenesis is complex, and an understanding of the driving factors of its pathogenesis…”
Get full text
Journal Article -
17
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody
Published in Clinical cancer research (15-07-2018)“…BRAF and MEK inhibitors (BRAF/MEKi) favor melanoma-infiltrating lymphocytes, providing the rationale for current combinatorial trials with anti-PD-1 antibody…”
Get full text
Journal Article -
18
New and emerging therapies in cutaneous T-cell lymphoma
Published in Dermatology reports (02-10-2024)“…Mycosis Fungoides (MF) is the most common cutaneous T-cell lymphoma that typically presents in the early phase as inflammatory erythematous patches or plaques,…”
Get full text
Journal Article -
19
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis
Published in Journal of the American Academy of Dermatology (01-10-2016)“…Background The infliximab originator's patent recently expired, leading to the production of biosimilar versions of the drug. The biosimilars' efficacy was not…”
Get full text
Journal Article -
20
Editorial: Cutaneous B-Cell Lymphomas
Published in Frontiers in oncology (09-12-2020)Get full text
Journal Article